Beaphar Multiwormer for Cats, Tablets

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: VMD (Veterinary Medicines Directorate)

Aktif bileşen:

Dichlorophen, Piperazine Citrate

Mevcut itibaren:

Beaphar UK Ltd

ATC kodu:

sQP52AG0

INN (International Adı):

Dichlorophen, Piperazine Citrate

Farmasötik formu:

Tablet

Reçete türü:

AVM-GSL - Authorised Veterinary Medicine – General Sales List

Terapötik grubu:

Cats

Terapötik alanı:

Anthelmintic anticestodal

Yetkilendirme durumu:

Authorized

Yetkilendirme tarihi:

1994-09-21

Ürün özellikleri

Revised: June 2018
AN: 00192/2018
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Beaphar Multiwormer for Cats, Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
TAPEWORM TABLETS (FAWN)
Active substance
mg/tablet
Dichlorophen
250.00
Excipients
mg/tablet
Caramel 15712 (E150)
4.0
For full list of excipients, see section 6.1
ROUNDWORM TABLETS (PINK)
Active substance
mg/tablet
Piperazine Citrate
125.00
Excipients
mg/tablet
Erythrocine Lake (E127)
0.25
For full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Tablets
Roundworm tablet: Slightly mottled pink, circular bi-convex tablet
embossed with an incomplete break-line on one face.
Tapeworm tablet: Mottled fawn to off-white, circular slightly
bi-convex
tablet embossed on one face with an incomplete break line.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats over 6 months of age
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of roundworm (Ascarids) and tapeworm infections in
cats over six months old
Revised: June 2018
AN: 00192/2018
Page 2 of 5
4.3
CONTRA-INDICATIONS
Do not treat cats less than 6 months old.
Do not repeat the treatment if vomiting occurs shortly after dosing.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Do not treat cats under 0.6 kg (1.5 lb), or less than 6 months old.
Do not repeat treatment if the cat vomits after administration.
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Consult a veterinary surgeon before treating animals with a
history of epilepsy or severe renal dysfunction.
It is important to establish the bodyweight of the animal before
treatment to ensure correct dosage administration.
ii.
Special precautions to be taken by the person administering the
medicinal product to animals
Wash hands thoroughly after handling tablets.
Accidental eye contact – rinse thoroughly with clean running
water.
If irritation persists seek medical advice.
Accidental ingestion by humans – drink plenty of water and seek
medical advice.
4.6
ADVERSE